A detailed history of Avoro Capital Advisors LLC transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 2,029,000 shares of MDGL stock, worth $631 Million. This represents 6.48% of its overall portfolio holdings.

Number of Shares
2,029,000
Previous 2,055,555 1.29%
Holding current value
$631 Million
Previous $576 Million 25.23%
% of portfolio
6.48%
Previous 7.86%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$212.22 - $292.96 $5.64 Million - $7.78 Million
-26,555 Reduced 1.29%
2,029,000 $431 Million
Q2 2024

Aug 14, 2024

BUY
$193.33 - $291.99 $21.5 Million - $32.4 Million
111,111 Added 5.71%
2,055,555 $576 Million
Q1 2024

May 15, 2024

BUY
$171.37 - $283.23 $9.52 Million - $15.7 Million
55,556 Added 2.94%
1,944,444 $519 Million
Q4 2023

Feb 14, 2024

BUY
$120.4 - $237.13 $40.2 Million - $79.2 Million
333,888 Added 21.47%
1,888,888 $437 Million
Q3 2023

Nov 14, 2023

BUY
$146.04 - $225.78 $5.82 Million - $9 Million
39,849 Added 2.63%
1,555,000 $227 Million
Q2 2023

Aug 14, 2023

SELL
$203.88 - $312.0 $30.9 Million - $47.3 Million
-151,515 Reduced 9.09%
1,515,151 $350 Million
Q1 2023

May 15, 2023

BUY
$231.06 - $307.08 $1.54 Million - $2.05 Million
6,666 Added 0.4%
1,666,666 $404 Million
Q4 2022

Feb 14, 2023

BUY
$58.39 - $296.54 $7.3 Million - $37.1 Million
125,000 Added 8.14%
1,660,000 $482 Million
Q2 2022

Aug 15, 2022

BUY
$58.04 - $100.2 $6.38 Million - $11 Million
110,000 Added 7.72%
1,535,000 $110 Million
Q1 2021

May 17, 2021

BUY
$108.54 - $125.2 $21.7 Million - $25 Million
200,000 Added 16.33%
1,425,000 $167 Million
Q4 2020

Feb 16, 2021

BUY
$110.06 - $133.7 $36.9 Million - $44.8 Million
335,000 Added 37.64%
1,225,000 $136 Million
Q3 2020

Nov 16, 2020

BUY
$99.78 - $124.21 $53.9 Million - $67.1 Million
540,000 Added 154.29%
890,000 $106 Million
Q2 2020

Aug 14, 2020

BUY
$60.13 - $125.71 $60,130 - $125,710
1,000 Added 0.29%
350,000 $39.6 Million
Q4 2019

Feb 14, 2020

SELL
$84.28 - $118.5 $927,080 - $1.3 Million
-11,000 Reduced 3.06%
349,000 $31.8 Million
Q2 2019

Aug 14, 2019

BUY
$91.13 - $142.5 $4.56 Million - $7.13 Million
50,000 Added 16.13%
360,000 $37.7 Million
Q1 2019

May 15, 2019

BUY
$103.48 - $143.84 $8.8 Million - $12.2 Million
85,000 Added 37.78%
310,000 $38.8 Million
Q4 2018

Feb 14, 2019

SELL
$94.77 - $215.54 $22.6 Million - $51.3 Million
-238,000 Reduced 51.4%
225,000 $25.4 Million
Q3 2018

Nov 14, 2018

SELL
$207.3 - $300.31 $5.5 Million - $7.97 Million
-26,536 Reduced 5.42%
463,000 $99.1 Million
Q2 2018

Aug 14, 2018

BUY
$101.55 - $313.9 $49.7 Million - $154 Million
489,536 New
489,536 $137 Million

Others Institutions Holding MDGL

About MADRIGAL PHARMACEUTICALS, INC.


  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.32B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Avoro Capital Advisors LLC Portfolio

Follow Avoro Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avoro Capital Advisors LLC with notifications on news.